查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1612890

细胞培养市场：按产品、应用和最终用途 - 2025-2030 年全球预测

Cell Culture Market by Product (Consumables, Equipment), Application (Biopharmaceutical Production, Diagnostics, Drug Screening & Development), End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年细胞培养市场价值为262.9亿美元，预计到2024年将达到301.2亿美元，复合年增长率为14.58%，到2030年将达到682亿美元。

细胞培养市场涉及在受控条件下在自然环境之外培养细胞，在生物研究、生物製药生产以及疫苗和治疗性蛋白质的製造中发挥至关重要的作用。由于生物技术的扩展、再生医学需求的快速增加以及对个人化医疗的日益关注，对此的需求正在增加。主要应用包括生物生产、药物发现、组织工程和临床应用，最终用户范围从製药公司和生物技术公司到研究机构和医院。该市场的成长受到自动化细胞培养系统技术进步、细胞研究资金增加以及需要创新治疗方法的慢性疾病盛行率上升的影响。 3D细胞培养系统的开发存在重大机会，可提供更好的生物模拟和基于细胞的产品製造的进步。公司可以透过与学术机构合作促进创新和建立生物库来支持个人化医疗而受益。然而，培养基和设备的高成本、有关动物性培养成分的伦理问题以及严格的法律规范等挑战可能会抑制生长。创新应着重于开发具有成本效益的介质和设备，整合人工智慧以提高实验室自动化，并增强大批量生产的製程可扩展性。鑑于市场的动态性质，以快速的技术发展和广泛的跨部门合作为特征，业务成长的最佳路径是在政府政策支持和医疗保健投资不断增加的新兴市场。透过建立强大的供应链并融入永续实践，您可以变得更具竞争力。对于希望增加市场占有率的公司来说，研发方面的策略性投资以及专注于为不同行业量身定制的解决方案代表着巨大的成长和成功潜力。

主要市场统计
基准年[2023] 262.9亿美元
预计年份 [2024] 301.2亿美元
预测年份 [2030] 682亿美元
复合年增长率（%） 14.58%

市场动态：揭示快速发展的细胞培养市场的关键市场洞察

供需的动态交互作用正在改变细胞培养市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 对治疗用途单株抗体的需求不断增长
    • 增加对生物技术和药物研究活动的投资
    • 全球慢性病盛行率上升
  • 市场限制因素
    • 与先进细胞培养技术和维持无菌条件相关的高成本
  • 市场机会
    • 扩大细胞培养在个人化医疗中的使用，提供个人遗传特征的治疗
    • 利用细胞培养进行永续食品生产的培养肉需求迅速成长
  • 市场问题
    • 培养物维护的复杂性与污染风险

波特的五力：驾驭细胞培养市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解细胞培养市场的外部影响

外部宏观环境因素在塑造细胞培养市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解细胞培养市场的竞争格局

对细胞培养市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：细胞培养市场供应商的绩效评估

FPNV定位矩阵是评估细胞培养市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製细胞培养市场的成功之路

细胞培养市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境，主要企业的广泛资料，评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、主要产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对治疗用途单株抗体的需求增加
      • 增加对生物技术和药物研究活动的投资
      • 世界各地慢性病的发生率正在上升
    • 抑制因素
      • 先进的细胞培养技术和维持无菌条件相关的高成本
    • 机会
      • 扩大细胞培养在个人化医疗的应用，根据个体的遗传特征客製化治疗方案
      • 利用细胞培养实现永续食品生产的培养肉需求不断增长
    • 任务
      • 培养物维护的复杂性与污染风险
  • 市场区隔分析
    • 产品：可靠、可扩展且先进的细胞培养设备正在成为优先考虑的因素
    • 最终用途：扩大细胞培养在医院和诊断实验室的使用，以提高效率和诊断准确性
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章细胞培养市场：副产品

  • 介绍
  • 消耗品
    • 反应器配件
    • 血清、培养基、试剂
      • 中等的
      • 经典介质和盐
      • 无血清培养基
      • 特殊介质
      • 干细胞培养基
      • 试剂
      • 抗生素/抗真菌药
      • 附件和矩阵因子
      • 平衡盐溶液
      • 缓衝液和化学品
      • 细胞分离试剂
      • 污染检测套件
      • 防冻试剂
      • 血清
      • 牛血清
      • 牛
    • 容器
      • 电池工厂系统/电池堆
      • 烧瓶
      • 多孔孔盘
      • 培养皿
      • 滚筒/娄瓶
  • 装置
    • 反应器
      • 常规反应器
      • 反应器
    • 仓储设备
      • 冷冻系统
      • 冰箱/冷冻库
    • 支援设备
      • 高压釜
      • 生物安全柜
      • 二氧化碳培养箱
      • 细胞计数器
      • 离心机
      • 过滤系统
      • 显微镜

第七章细胞培养市场：依应用分类

  • 介绍
  • 生物製药製造
    • 单株抗体的生产
    • 疫苗生产
  • 诊断
  • 药物筛检与开发
  • 干细胞研究
  • 组织工程与再生医学

第八章细胞培养市场：依最终用途

  • 介绍
  • 医院和诊断实验室
  • 製药和生物技术公司
  • 研究/学术机构

第九章美洲细胞培养市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太细胞培养市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲细胞培养市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 诺华在奥地利生物製药製造领域启动 5 亿美元扩建计划
    • Molecular Devices 宣布推出 CellXpress AI 自动化系统
    • 策略伙伴关係提高干细胞研究的可及性和效率
  • 战略分析和建议

公司名单

  • Adolf Kuhner AG
  • Advancion Corporation
  • Agilent Technologies, Inc.
  • Becton, Dickinson, and Company
  • Bio-Techne Corporation
  • BioSpherix Ltd.
  • Caisson Labs Inc.
  • CellGenix GmbH
  • Corning Incorporated
  • Danaher Corporation
  • Emulate, Inc.
  • Eppendorf AG
  • Fujifilm Holdings Corporation
  • Getinge AB
  • Hi-Media Laboratories
  • InSphero AG
  • Invivogen
  • Lonza Group
  • Merck & Co., Inc.
  • Miltenyi BIoTec
  • PAN-BIoTech GmbH
  • PromoCell GmbH
  • Sartorius AG
  • Solida BIoTech GmBH
  • STEMCELL Technologies Canada Inc.
  • Synthecon, Incorporated
  • Thermo Fisher Scientific Inc.
  • VWR International, LLC by Avantor, Inc.
Product Code: MRR-034230D3E63B

The Cell Culture Market was valued at USD 26.29 billion in 2023, expected to reach USD 30.12 billion in 2024, and is projected to grow at a CAGR of 14.58%, to USD 68.20 billion by 2030.

The cell culture market involves the cultivation of cells outside their natural environment under controlled conditions and plays a pivotal role in biological research, biopharmaceutical production, and manufacturing of vaccines and therapeutic proteins. It is increasingly necessary due to the expansion of biotechnology, the surge in demand for regenerative medicine, and the increasing focus on personalized medicine. Key applications include bioproduction, drug discovery, tissue engineering, and clinical applications with end users spanning pharmaceutical and biotechnology companies, research institutes, and hospitals. Growth in this market is influenced by technological advancements in automated cell culture systems, increased funding for cell-based research, and the rising prevalence of chronic diseases that require innovative therapies. Opportunities are substantial in the development of three-dimensional cell culture systems, which offer better biomimicry, and in the advancement of cell-based product manufacturing. Companies can benefit from partnerships with academic institutions to foster innovation and the establishment of biobanks to support personalized medicine. However, challenges such as high costs of cell culture media and equipment, ethical concerns regarding animal-derived culture components, and stringent regulatory frameworks may impede growth. Innovation should focus on developing cost-efficient culture media and equipment, integrating artificial intelligence for better lab automation, and enhancing the scalability of processes for mass production. Given the dynamic nature of the market, characterized by rapid technological evolution and extensive collaboration across disciplines, the best avenues for business growth lie in emerging markets with supportive government policies and increasing healthcare investments. Establishing a robust supply chain and incorporating sustainable practices can further enhance competitiveness. For companies aiming to expand their market share, strategic investments in R&D, coupled with a focus on tailored solutions for varied industries, offer significant potential for growth and success.

KEY MARKET STATISTICS
Base Year [2023] USD 26.29 billion
Estimated Year [2024] USD 30.12 billion
Forecast Year [2030] USD 68.20 billion
CAGR (%) 14.58%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cell Culture Market

The Cell Culture Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing demand for monoclonal antibodies for therapeutic applications
    • Increased investment in biotechnology and pharmaceutical research activities
    • Rising incidence of chronic diseases worldwide
  • Market Restraints
    • High cost associated with advanced cell culture technologies and the maintenance of sterile conditions
  • Market Opportunities
    • Expanding the use of cell culture in personalized medicine for tailored treatments to individual genetic profiles
    • Burgeoning demand for cultured meat, using cell culture for sustainable food production
  • Market Challenges
    • The complexity of maintaining cultures and the risk of contamination

Porter's Five Forces: A Strategic Tool for Navigating the Cell Culture Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cell Culture Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cell Culture Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cell Culture Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cell Culture Market

A detailed market share analysis in the Cell Culture Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cell Culture Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cell Culture Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cell Culture Market

A strategic analysis of the Cell Culture Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell Culture Market, highlighting leading vendors and their innovative profiles. These include Adolf Kuhner AG, Advancion Corporation, Agilent Technologies, Inc., Becton, Dickinson, and Company, Bio-Techne Corporation, BioSpherix Ltd., Caisson Labs Inc., CellGenix GmbH, Corning Incorporated, Danaher Corporation, Emulate, Inc., Eppendorf AG, Fujifilm Holdings Corporation, Getinge AB, Hi-Media Laboratories, InSphero AG, Invivogen, Lonza Group, Merck & Co., Inc., Miltenyi Biotec, PAN-Biotech GmbH, PromoCell GmbH, Sartorius AG, Solida Biotech GmBH, STEMCELL Technologies Canada Inc., Synthecon, Incorporated, Thermo Fisher Scientific Inc., and VWR International, LLC by Avantor, Inc..

Market Segmentation & Coverage

This research report categorizes the Cell Culture Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables and Equipment. The Consumables is further studied across Bioreactor Accessories, Sera, Media, and Reagents, and Vessels. The Sera, Media, and Reagents is further studied across Media, Reagents, and Sera. The Media is further studied across Classical Media & Salts, Serum-Free Media, Specialty Media, and Stem Cell Culture Media. The Reagents is further studied across Antibiotics/Antimycotics, Attachment & Matrix Factors, Balanced Salt Solutions, Buffers & Chemicals, Cell Dissociation Reagents, Contamination Detection Kits, and Cryoprotective Reagents. The Sera is further studied across Adult Bovine Sera and Fetal Bovine Sera. The Vessels is further studied across Cell Factory Systems/Cell Stacks, Flasks, Multiwell Plates, Petri Dishes, and Roller/Roux Bottles. The Equipment is further studied across Bioreactors, Storage Equipment, and Supporting Equipment. The Bioreactors is further studied across Conventional Bioreactors and Single-Use Bioreactors. The Storage Equipment is further studied across Cryostorage System and Refrigerators & Freezers. The Supporting Equipment is further studied across Autoclaves, Biosafety Cabinets, Carbon Dioxide Incubators, Cell Counters, Centrifuges, Filtration System, and Microscopes.
  • Based on Application, market is studied across Biopharmaceutical Production, Diagnostics, Drug Screening & Development, Stem Cell Research, and Tissue Engineering & Regenerative Medicine. The Biopharmaceutical Production is further studied across Monoclonal Antibody Production and Vaccine Production.
  • Based on End-Use, market is studied across Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Research & Academic Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for monoclonal antibodies for therapeutic applications
      • 5.1.1.2. Increased investment in biotechnology and pharmaceutical research activities
      • 5.1.1.3. Rising incidence of chronic diseases worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with advanced cell culture technologies and the maintenance of sterile conditions
    • 5.1.3. Opportunities
      • 5.1.3.1. Expanding the use of cell culture in personalized medicine for tailored treatments to individual genetic profiles
      • 5.1.3.2. Burgeoning demand for cultured meat, using cell culture for sustainable food production
    • 5.1.4. Challenges
      • 5.1.4.1. The complexity of maintaining cultures and the risk of contamination
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Increasing preference for equipments in cell culture for reliability, scalability, and advanced features
    • 5.2.2. End-Use: Expanding usage of cell culture in hospitals and diagnostic laboratories for efficiency and diagnostic accuracy
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cell Culture Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.2.1. Bioreactor Accessories
    • 6.2.2. Sera, Media, and Reagents
      • 6.2.2.1. Media
      • 6.2.2.1.1. Classical Media & Salts
      • 6.2.2.1.2. Serum-Free Media
      • 6.2.2.1.3. Specialty Media
      • 6.2.2.1.4. Stem Cell Culture Media
      • 6.2.2.2. Reagents
      • 6.2.2.2.1. Antibiotics/Antimycotics
      • 6.2.2.2.2. Attachment & Matrix Factors
      • 6.2.2.2.3. Balanced Salt Solutions
      • 6.2.2.2.4. Buffers & Chemicals
      • 6.2.2.2.5. Cell Dissociation Reagents
      • 6.2.2.2.6. Contamination Detection Kits
      • 6.2.2.2.7. Cryoprotective Reagents
      • 6.2.2.3. Sera
      • 6.2.2.3.1. Adult Bovine Sera
      • 6.2.2.3.2. Fetal Bovine Sera
    • 6.2.3. Vessels
      • 6.2.3.1. Cell Factory Systems/Cell Stacks
      • 6.2.3.2. Flasks
      • 6.2.3.3. Multiwell Plates
      • 6.2.3.4. Petri Dishes
      • 6.2.3.5. Roller/Roux Bottles
  • 6.3. Equipment
    • 6.3.1. Bioreactors
      • 6.3.1.1. Conventional Bioreactors
      • 6.3.1.2. Single-Use Bioreactors
    • 6.3.2. Storage Equipment
      • 6.3.2.1. Cryostorage System
      • 6.3.2.2. Refrigerators & Freezers
    • 6.3.3. Supporting Equipment
      • 6.3.3.1. Autoclaves
      • 6.3.3.2. Biosafety Cabinets
      • 6.3.3.3. Carbon Dioxide Incubators
      • 6.3.3.4. Cell Counters
      • 6.3.3.5. Centrifuges
      • 6.3.3.6. Filtration System
      • 6.3.3.7. Microscopes

7. Cell Culture Market, by Application

  • 7.1. Introduction
  • 7.2. Biopharmaceutical Production
    • 7.2.1. Monoclonal Antibody Production
    • 7.2.2. Vaccine Production
  • 7.3. Diagnostics
  • 7.4. Drug Screening & Development
  • 7.5. Stem Cell Research
  • 7.6. Tissue Engineering & Regenerative Medicine

8. Cell Culture Market, by End-Use

  • 8.1. Introduction
  • 8.2. Hospitals & Diagnostic Laboratories
  • 8.3. Pharmaceutical & Biotechnology Companies
  • 8.4. Research & Academic Institutes

9. Americas Cell Culture Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cell Culture Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cell Culture Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Novartis Embarks on a USD 500 Million Expansion Project in Austrian Biopharmaceutical Manufacturing
    • 12.3.2. Molecular Devices Unveils the CellXpress AI Automated Cell Culture System
    • 12.3.3. Strategic Alliance Elevates Stem Cell Research Accessibility and Efficiency
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Adolf Kuhner AG
  • 2. Advancion Corporation
  • 3. Agilent Technologies, Inc.
  • 4. Becton, Dickinson, and Company
  • 5. Bio-Techne Corporation
  • 6. BioSpherix Ltd.
  • 7. Caisson Labs Inc.
  • 8. CellGenix GmbH
  • 9. Corning Incorporated
  • 10. Danaher Corporation
  • 11. Emulate, Inc.
  • 12. Eppendorf AG
  • 13. Fujifilm Holdings Corporation
  • 14. Getinge AB
  • 15. Hi-Media Laboratories
  • 16. InSphero AG
  • 17. Invivogen
  • 18. Lonza Group
  • 19. Merck & Co., Inc.
  • 20. Miltenyi Biotec
  • 21. PAN-Biotech GmbH
  • 22. PromoCell GmbH
  • 23. Sartorius AG
  • 24. Solida Biotech GmBH
  • 25. STEMCELL Technologies Canada Inc.
  • 26. Synthecon, Incorporated
  • 27. Thermo Fisher Scientific Inc.
  • 28. VWR International, LLC by Avantor, Inc.

LIST OF FIGURES

  • FIGURE 1. CELL CULTURE MARKET RESEARCH PROCESS
  • FIGURE 2. CELL CULTURE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CELL CULTURE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CELL CULTURE MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CELL CULTURE MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CELL CULTURE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CELL CULTURE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CELL CULTURE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CELL CULTURE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CELL CULTURE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CELL CULTURE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CELL CULTURE MARKET DYNAMICS
  • TABLE 7. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CELL CULTURE MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTOR ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CELL CULTURE MARKET SIZE, BY MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CELL CULTURE MARKET SIZE, BY CLASSICAL MEDIA & SALTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CELL CULTURE MARKET SIZE, BY SERUM-FREE MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CELL CULTURE MARKET SIZE, BY SPECIALTY MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CELL CULTURE MARKET SIZE, BY STEM CELL CULTURE MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CELL CULTURE MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CELL CULTURE MARKET SIZE, BY ANTIBIOTICS/ANTIMYCOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CELL CULTURE MARKET SIZE, BY ATTACHMENT & MATRIX FACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CELL CULTURE MARKET SIZE, BY BALANCED SALT SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CELL CULTURE MARKET SIZE, BY BUFFERS & CHEMICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CELL CULTURE MARKET SIZE, BY CELL DISSOCIATION REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CELL CULTURE MARKET SIZE, BY CONTAMINATION DETECTION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CELL CULTURE MARKET SIZE, BY CRYOPROTECTIVE REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CELL CULTURE MARKET SIZE, BY ADULT BOVINE SERA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CELL CULTURE MARKET SIZE, BY FETAL BOVINE SERA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CELL CULTURE MARKET SIZE, BY VESSELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CELL CULTURE MARKET SIZE, BY CELL FACTORY SYSTEMS/CELL STACKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CELL CULTURE MARKET SIZE, BY FLASKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CELL CULTURE MARKET SIZE, BY MULTIWELL PLATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CELL CULTURE MARKET SIZE, BY PETRI DISHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CELL CULTURE MARKET SIZE, BY ROLLER/ROUX BOTTLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CELL CULTURE MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL CELL CULTURE MARKET SIZE, BY CONVENTIONAL BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL CELL CULTURE MARKET SIZE, BY SINGLE-USE BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL CELL CULTURE MARKET SIZE, BY CRYOSTORAGE SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL CELL CULTURE MARKET SIZE, BY REFRIGERATORS & FREEZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL CELL CULTURE MARKET SIZE, BY AUTOCLAVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL CELL CULTURE MARKET SIZE, BY BIOSAFETY CABINETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL CELL CULTURE MARKET SIZE, BY CARBON DIOXIDE INCUBATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL CELL CULTURE MARKET SIZE, BY CELL COUNTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL CELL CULTURE MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL CELL CULTURE MARKET SIZE, BY FILTRATION SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL CELL CULTURE MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL CELL CULTURE MARKET SIZE, BY MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL CELL CULTURE MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL CELL CULTURE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL CELL CULTURE MARKET SIZE, BY DRUG SCREENING & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 65. GLOBAL CELL CULTURE MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 66. GLOBAL CELL CULTURE MARKET SIZE, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 67. GLOBAL CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. GLOBAL CELL CULTURE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 69. GLOBAL CELL CULTURE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 70. GLOBAL CELL CULTURE MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 71. AMERICAS CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. AMERICAS CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 73. AMERICAS CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 74. AMERICAS CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 75. AMERICAS CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 76. AMERICAS CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 77. AMERICAS CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 78. AMERICAS CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 79. AMERICAS CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 80. AMERICAS CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 81. AMERICAS CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 82. AMERICAS CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. AMERICAS CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 84. AMERICAS CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 85. AMERICAS CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. ARGENTINA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. ARGENTINA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 88. ARGENTINA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 89. ARGENTINA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 90. ARGENTINA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 91. ARGENTINA CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 92. ARGENTINA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 93. ARGENTINA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 94. ARGENTINA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 95. ARGENTINA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 96. ARGENTINA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 97. ARGENTINA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ARGENTINA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 99. ARGENTINA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. BRAZIL CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. BRAZIL CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 102. BRAZIL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 103. BRAZIL CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 104. BRAZIL CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 105. BRAZIL CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 106. BRAZIL CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 107. BRAZIL CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 108. BRAZIL CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 109. BRAZIL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 110. BRAZIL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 111. BRAZIL CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. BRAZIL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 113. BRAZIL CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 114. CANADA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. CANADA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 116. CANADA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 117. CANADA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 118. CANADA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 119. CANADA CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 120. CANADA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 121. CANADA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 122. CANADA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 123. CANADA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 124. CANADA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 125. CANADA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. CANADA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 127. CANADA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 128. MEXICO CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. MEXICO CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 130. MEXICO CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 131. MEXICO CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 132. MEXICO CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 133. MEXICO CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 134. MEXICO CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 135. MEXICO CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 136. MEXICO CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 137. MEXICO CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 138. MEXICO CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 139. MEXICO CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. MEXICO CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 141. MEXICO CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED STATES CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED STATES CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED STATES CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED STATES CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED STATES CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED STATES CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED STATES CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED STATES CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED STATES CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED STATES CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 152. UNITED STATES CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 153. UNITED STATES CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. UNITED STATES CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 155. UNITED STATES CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 156. UNITED STATES CELL CULTURE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 172. AUSTRALIA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. AUSTRALIA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 174. AUSTRALIA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 175. AUSTRALIA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 176. AUSTRALIA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 177. AUSTRALIA CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 178. AUSTRALIA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 179. AUSTRALIA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 180. AUSTRALIA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 181. AUSTRALIA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 182. AUSTRALIA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 183. AUSTRALIA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. AUSTRALIA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 185. AUSTRALIA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 186. CHINA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. CHINA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 188. CHINA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 189. CHINA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 190. CHINA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 191. CHINA CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 192. CHINA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 193. CHINA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 194. CHINA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 195. CHINA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 196. CHINA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 197. CHINA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. CHINA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 199. CHINA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 200. INDIA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. INDIA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 202. INDIA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 203. INDIA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 204. INDIA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 205. INDIA CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 206. INDIA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 207. INDIA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 208. INDIA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 209. INDIA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 210. INDIA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 211. INDIA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. INDIA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 213. INDIA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 214. INDONESIA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. INDONESIA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 216. INDONESIA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 217. INDONESIA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 218. INDONESIA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 219. INDONESIA CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 220. INDONESIA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 221. INDONESIA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 222. INDONESIA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 223. INDONESIA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 224. INDONESIA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 225. INDONESIA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. INDONESIA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 227. INDONESIA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 228. JAPAN CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. JAPAN CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 230. JAPAN CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 231. JAPAN CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 232. JAPAN CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 233. JAPAN CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 234. JAPAN CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 235. JAPAN CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 236. JAPAN CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 237. JAPAN CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 238. JAPAN CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 239. JAPAN CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. JAPAN CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 241. JAPAN CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 242. MALAYSIA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 243. MALAYSIA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 244. MALAYSIA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 245. MALAYSIA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 246. MALAYSIA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 247. MALAYSIA CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 248. MALAYSIA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 249. MALAYSIA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 250. MALAYSIA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 251. MALAYSIA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 252. MALAYSIA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 253. MALAYSIA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 254. MALAYSIA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 255. MALAYSIA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 256. PHILIPPINES CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 257. PHILIPPINES CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 258. PHILIPPINES CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 259. PHILIPPINES CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 260. PHILIPPINES CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 261. PHILIPPINES CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 262. PHILIPPINES CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 263. PHILIPPINES CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 264. PHILIPPINES CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 265. PHILIPPINES CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 266. PHILIPPINES CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 267. PHILIPPINES CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. PHILIPPINES CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 269. PHILIPPINES CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 270. SINGAPORE CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 271. SINGAPORE CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 272. SINGAPORE CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 273. SINGAPORE CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 274. SINGAPORE CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 275. SINGAPORE CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 276. SINGAPORE CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 277. SINGAPORE CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 278. SINGAPORE CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 279. SINGAPORE CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 280. SINGAPORE CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 281. SINGAPORE CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 282. SINGAPORE CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 283. SINGAPORE CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH KOREA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH KOREA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH KOREA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 287. SOUTH KOREA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 288. SOUTH KOREA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 289. SOUTH KOREA CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 290. SOUTH KOREA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 291. SOUTH KOREA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 292. SOUTH KOREA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 293. SOUTH KOREA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 294. SOUTH KOREA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 295. SOUTH KOREA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 296. SOUTH KOREA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 297. SOUTH KOREA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 298. TAIWAN CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 299. TAIWAN CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 300. TAIWAN CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 301. TAIWAN CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 302. TAIWAN CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 303. TAIWAN CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 304. TAIWAN CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 305. TAIWAN CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 306. TAIWAN CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 307. TAIWAN CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 308. TAIWAN CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 309. TAIWAN CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 310. TAIWAN CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 311. TAIWAN CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 312. THAILAND CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 313. THAILAND CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 314. THAILAND CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 315. THAILAND CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 316. THAILAND CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 317. THAILAND CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 318. THAILAND CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 319. THAILAND CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 320. THAILAND CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 321. THAILAND CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 322. THAILAND CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 323. THAILAND CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 324. THAILAND CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 325. THAILAND CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 326. VIETNAM CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 327. VIETNAM CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 328. VIETNAM CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 329. VIETNAM CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 330. VIETNAM CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 331. VIETNAM CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 332. VIETNAM CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 333. VIETNAM CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 334. VIETNAM CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 335. VIETNAM CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 336. VIETNAM CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 337. VIETNAM CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 338. VIETNAM CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 339. VIETNAM CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 340. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 341. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 342. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 343. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 344. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 345. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 346. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 347. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 348. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 349. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 350. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 351. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 352. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 353. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 354. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 355. DENMARK CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 356. DENMARK CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 357. DENMARK CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 358. DENMARK CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 359. DENMARK CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 360. DENMARK CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 361. DENMARK CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 362. DENMARK CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 363. DENMARK CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 364. DENMARK CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 365. DENMARK CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 366. DENMARK CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 367. DENMARK CELL CULTURE MARKET SIZE, BY BIOP